Close Menu

NEW YORK (GenomeWeb) – Great Basin Scientific today reported that its first quarter revenues rose 14 percent year over year, driven primarily by an 82 percent increase in sales of its Group B Strep assay. 

For the three months ended March 31, the Salt Lake City-based firm reported revenue of $830,777, up from $731,422 in the first quarter of 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.